Brief: Biohaven Announces Investment Up To $600 Mln By Oberland Capital
28/04/2025 13:12
April 28 (Reuters) - Biohaven Ltd BHVN.N: BIOHAVEN ANNOUNCES INVESTMENT UP TO $600 MILLION BY OBERLAND CAPITAL BIOHAVEN LTD - OBERLAND CAPITAL TO RECEIVE MILESTONE AND ROYALTY PAYMENTS ON NET SALES OF TRORILUZOLE Source text: ID:nPnc6Q9Qa Further company coverage: BHVN.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biohaven
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
Brief: Biohaven - FDA Accepts Biohaven NDA Resubmission For Vyglxia (Troriluzole) In SCA
Biohaven jumps as FDA takes second look at brain disorder drug
Brief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean